O15269 (SPTC1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 123.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Serine palmitoyltransferase 1 EC=2.3.1.50 Alternative name(s): Long chain base biosynthesis protein 1 Short name=LCB 1 Serine-palmitoyl-CoA transferase 1 Short name=SPT 1 Short name=SPT1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 473 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine palmitoyltransferase (SPT). The heterodimer formed with SPTLC2 or SPTLC3 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SPTSSA isozyme uses both C14-CoA and C16-CoA as substrates, with a slight preference for C14-CoA. The SPTLC1-SPTLC2-SPTSSB complex shows a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-SPTSSB isozyme displays an ability to use a broader range of acyl-CoAs, without apparent preference. Ref.8 |
| Catalytic activity | Palmitoyl-CoA + L-serine = CoA + 3-dehydro-D-sphinganine + CO2. Ref.8 |
| Cofactor | Pyridoxal phosphate By similarity. |
| Pathway | |
| Subunit structure | Heterodimer with SPTLC2 or SPTLC3. Component of the serine palmitoyltransferase (SPT) complex, composed of SPTLC1, either SPTLC2 or SPTLC3, and either SPTSSA or SPTSSB. Interacts with SPTSSA and SPTSSB; the interaction is direct. Interacts with ORMDL3. Ref.8 Ref.10 |
| Subcellular location | Endoplasmic reticulum membrane; Single-pass membrane protein By similarity. |
| Tissue specificity | Widely expressed. Not detected in small intestine. Ref.7 |
| Involvement in disease | Hereditary sensory and autonomic neuropathy 1A (HSAN1A) [MIM:162400]: A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by prominent sensory abnormalities with a variable degree of motor and autonomic dysfunction. The neurological phenotype is often complicated by severe infections, osteomyelitis, and amputations. HSAN1A is an autosomal dominant axonal form with onset in the second or third decades. Initial symptoms are loss of pain, touch, heat, and cold sensation over the feet, followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic skin ulcers and distal amputations. |
| Sequence similarities | Belongs to the class-II pyridoxal-phosphate-dependent aminotransferase family. |
| Caution | Variant Ala-387 has been originally thought to cause HSAN1A (Ref.12). Subsequently, it has been shown to be a rare, benign polymorphism found in homozygous state in a healthy individual (Ref.16). |
| Biophysicochemical properties | Kinetic parameters: KM=0.75 mM for serine Ref.9 Vmax=1350 pmol/min/mg enzyme |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O15269-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O15269-2) The sequence of this isoform differs from the canonical sequence as follows: 143-143: D → E 144-473: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 473 | 473 | Serine palmitoyltransferase 1 | PRO_0000163853 | |||||
Regions | |||||||||
| Topological domain | 1 – 15 | 15 | Lumenal Potential | ||||||
| Transmembrane | 16 – 36 | 21 | Helical; Potential | ||||||
| Topological domain | 37 – 473 | 437 | Cytoplasmic Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 143 | 1 | D → E in isoform 2. | VSP_043127 | |||||
| Alternative sequence | 144 – 473 | 330 | Missing in isoform 2. | VSP_043128 | |||||
| Natural variant | 133 | 1 | C → W in HSAN1A; inactive in the heterodimeric SPT complex; largely reduced activity with serine as substrate, but nearly no effect on serine affinity in the heterotrimeric SPT complex; in contrast to wild-type is able to use alanine as substrate leading to the formation of 1-deoxysphinganine (1-deoxySa); does not interfere with SPT complex formation. Ref.2 Ref.9 Ref.16 Ref.18 | VAR_011392 | |||||
| Natural variant | 133 | 1 | C → Y in HSAN1A; reduced activity; does not interfere with SPT complex formation. Ref.2 Ref.16 | VAR_011393 | |||||
| Natural variant | 144 | 1 | V → D in HSAN1A; reduced activity; does not interfere with SPT complex formation. Ref.2 Ref.16 | VAR_011394 | |||||
| Natural variant | 151 | 1 | R → L. Ref.13 Corresponds to variant rs45461899 [ dbSNP | Ensembl ]. | VAR_037889 | |||||
| Natural variant | 239 | 1 | R → W in a breast cancer sample; somatic mutation. Ref.14 | VAR_036610 | |||||
| Natural variant | 310 | 1 | A → G Found in a patient with HSAN1A; uncertain pathological significance. Ref.18 | VAR_068476 | |||||
| Natural variant | 331 | 1 | S → F in HSAN1A; reduced activity. Ref.15 Ref.17 | VAR_066245 | |||||
| Natural variant | 352 | 1 | A → V in HSAN1A; reduced activity. Ref.15 Ref.17 | VAR_066246 | |||||
| Natural variant | 387 | 1 | G → A Rare polymorphism; does not affect activity; does not interfere with SPT complex formation. Ref.12 Ref.16 | VAR_037890 | |||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human and murine serine-palmitoyl-CoA transferase. Cloning, expression and characterization of the key enzyme in sphingolipid synthesis." Weiss B., Stoffel W. Eur. J. Biochem. 249:239-247(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Kidney. |
| [2] | "Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I." Dawkins J.L., Hulme D.J., Brahmbhatt S.B., Auer-Grumbach M., Nicholson G.A. Nat. Genet. 27:309-312(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANTS HSAN1A TRP-133; TYR-133 AND ASP-144. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Placenta. |
| [4] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain. |
| [7] | "Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase." Hornemann T., Richard S., Ruetti M.F., Wei Y., von Eckardstein A. J. Biol. Chem. 281:37275-37281(2006) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [8] | "Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities." Han G., Gupta S.D., Gable K., Niranjanakumari S., Moitra P., Eichler F., Brown R.H. Jr., Harmon J.M., Dunn T.M. Proc. Natl. Acad. Sci. U.S.A. 106:8186-8191(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, IDENTIFICATION IN THE SPT COMPLEX, INTERACTION WITH SPTSSA AND SPTSSB. |
| [9] | "A disease-causing mutation in the active site of serine palmitoyltransferase causes catalytic promiscuity." Gable K., Gupta S.D., Han G., Niranjanakumari S., Harmon J.M., Dunn T.M. J. Biol. Chem. 285:22846-22852(2010) [PubMed] [Europe PMC] [Abstract] Cited for: BIOPHYSICOCHEMICAL PROPERTIES, CHARACTERIZATION OF VARIANT HSAN1A TRP-133. |
| [10] | "Orm family proteins mediate sphingolipid homeostasis." Breslow D.K., Collins S.R., Bodenmiller B., Aebersold R., Simons K., Shevchenko A., Ejsing C.S., Weissman J.S. Nature 463:1048-1053(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ORMDL3. |
| [11] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [12] | "SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I." Verhoeven K., Coen K., De Vriendt E., Jacobs A., Van Gerwen V., Smouts I., Pou-Serradell A., Martin J.-J., Timmerman V., De Jonghe P. Neurology 62:1001-1002(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ALA-387. |
| [13] | "Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene." Meggouh F., Bienfait H.M.E., Weterman M.A.J., de Visser M., Baas F. Neurology 67:1476-1478(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT LEU-151. |
| [14] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] TRP-239. |
| [15] | "Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation." Rotthier A., Baets J., De Vriendt E., Jacobs A., Auer-Grumbach M., Levy N., Bonello-Palot N., Kilic S.S., Weis J., Nascimento A., Swinkels M., Kruyt M.C., Jordanova A., De Jonghe P., Timmerman V. Brain 132:2699-2711(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS HSAN1A PHE-331 AND VAL-352. |
| [16] | "A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated." Hornemann T., Penno A., Richard S., Nicholson G., van Dijk F.S., Rotthier A., Timmerman V., von Eckardstein A. Neurogenetics 10:135-143(2009) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANTS HSAN1A TYR-133; TRP-133 AND ASP-144, CHARACTERIZATION OF VARIANT ALA-387, LACK OF ASSOCIATION OF VARIANT ALA-387 WITH HSAN1A. |
| [17] | "Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I." Rotthier A., Penno A., Rautenstrauss B., Auer-Grumbach M., Stettner G.M., Asselbergh B., Van Hoof K., Sticht H., Levy N., Timmerman V., Hornemann T., Janssens K. Hum. Mutat. 32:E2211-E2225(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT HSAN1A PHE-331, CHARACTERIZATION OF VARIANTS HSAN1A PHE-331 AND VAL-352. |
| [18] | "Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort." Davidson G.L., Murphy S.M., Polke J.M., Laura M., Salih M.A., Muntoni F., Blake J., Brandner S., Davies N., Horvath R., Price S., Donaghy M., Roberts M., Foulds N., Ramdharry G., Soler D., Lunn M.P., Manji H. Reilly M.M.J. Neurol. 259:1673-1685(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT HSAN1A TRP-133, VARIANT GLY-310. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | Y08685 mRNA. Translation: CAA69941.1. AF286717 AF286716 Genomic DNA. Translation: AAK29328.1.AK291546 mRNA. Translation: BAF84235.1. AL391219, AL354751 Genomic DNA. Translation: CAH70209.1. AL354751 Genomic DNA. Translation: CAH69923.1. AL354751, AL391219 Genomic DNA. Translation: CAH69924.1. CH471089 Genomic DNA. Translation: EAW62804.1. BC007085 mRNA. Translation: AAH07085.1. |
| IPI | IPI00005745. IPI00259092. |
| RefSeq | NP_006406.1. NM_006415.2. NP_847894.1. NM_178324.1. |
| UniGene | Hs.90458. |
3D structure databases | |
| ProteinModelPortal | O15269. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-45626N. |
| IntAct | O15269. 7 interactions. |
| STRING | 9606.ENSP00000262554. |
PTM databases | |
| PhosphoSite | O15269. |
Proteomic databases | |
| PaxDb | O15269. |
| PeptideAtlas | O15269. |
| PRIDE | O15269. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000262554; ENSP00000262554; ENSG00000090054. ENST00000337841; ENSP00000337635; ENSG00000090054. |
| GeneID | 10558. |
| KEGG | hsa:10558. |
| UCSC | uc004arl.1. human. |
Organism-specific databases | |
| CTD | 10558. |
| GeneCards | GC09M094793. |
| H-InvDB | HIX0034871. |
| HGNC | HGNC:11277. SPTLC1. |
| HPA | CAB018747. HPA010860. |
| MIM | 162400. phenotype. 605712. gene. |
| neXtProt | NX_O15269. |
| Orphanet | 36386. Hereditary sensory and autonomic neuropathy type 1. |
| PharmGKB | PA36106. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0156. |
| HOGENOM | HOG000216602. |
| HOVERGEN | HBG003992. |
| InParanoid | O15269. |
| KO | K00654. |
| OMA | TEEAILY. |
| OrthoDB | EOG4XPQFX. |
| PhylomeDB | O15269. |
Enzyme and pathway databases | |
| BRENDA | 2.3.1.50. 2681. |
| Reactome | REACT_111217. Metabolism. |
| UniPathway | UPA00222. |
Gene expression databases | |
| ArrayExpress | O15269. |
| Bgee | O15269. |
| CleanEx | HS_SPTLC1. |
| Genevestigator | O15269. |
| GermOnline | ENSG00000090054. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.40.640.10. 1 hit. 3.90.1150.10. 1 hit. |
| InterPro | IPR004839. Aminotransferase_I/II. IPR015424. PyrdxlP-dep_Trfase. IPR015421. PyrdxlP-dep_Trfase_major_sub1. IPR015422. PyrdxlP-dep_Trfase_major_sub2. [Graphical view] |
| Pfam | PF00155. Aminotran_1_2. 1 hit. [Graphical view] |
| SUPFAM | SSF53383. PyrdxlP-dep_Trfase_major. 1 hit. |
| PROSITE | PS00599. AA_TRANSFER_CLASS_2. False negative. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | O15269. |
| ChEMBL | CHEMBL1250343. |
| ChiTaRS | SPTLC1. human. |
| DrugBank | DB00133. L-Serine. DB00114. Pyridoxal Phosphate. |
| GenomeRNAi | 10558. |
| NextBio | 40067. |
| SOURCE | Search... |
Entry information
| Entry name | SPTC1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O15269 Secondary accession number(s): A8K681, Q5VWB4, Q96IX6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
